These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 31004503)
1. In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies. Marvian AT; Koss DJ; Aliakbari F; Morshedi D; Outeiro TF J Neurochem; 2019 Sep; 150(5):535-565. PubMed ID: 31004503 [TBL] [Abstract][Full Text] [Related]
2. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy. Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358 [TBL] [Abstract][Full Text] [Related]
3. Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies. Karpowicz RJ; Haney CM; Mihaila TS; Sandler RM; Petersson EJ; Lee VM J Biol Chem; 2017 Aug; 292(32):13482-13497. PubMed ID: 28611062 [TBL] [Abstract][Full Text] [Related]
4. Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery. Arotcarena ML; Teil M; Dehay B Cells; 2019 Jun; 8(6):. PubMed ID: 31181865 [TBL] [Abstract][Full Text] [Related]
5. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies. Henderson MX; Trojanowski JQ; Lee VM Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426 [TBL] [Abstract][Full Text] [Related]
6. α-Synuclein aggregation and transmission in Parkinson's disease: a link to mitochondria and lysosome. Wang R; Sun H; Ren H; Wang G Sci China Life Sci; 2020 Dec; 63(12):1850-1859. PubMed ID: 32681494 [TBL] [Abstract][Full Text] [Related]
7. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration. Mahul-Mellier AL; Burtscher J; Maharjan N; Weerens L; Croisier M; Kuttler F; Leleu M; Knott GW; Lashuel HA Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4971-4982. PubMed ID: 32075919 [TBL] [Abstract][Full Text] [Related]
8. Associations Between APOE Variants, Tau and α-Synuclein. Rodriguez-Vieitez E; Nielsen HM Adv Exp Med Biol; 2019; 1184():177-186. PubMed ID: 32096038 [TBL] [Abstract][Full Text] [Related]
9. GV-971 attenuates α-Synuclein aggregation and related pathology. Yu Z; Yang Y; Chan RB; Shi M; Stewart T; Huang Y; Liu Z; Lan G; Sheng L; Tian C; Yang D; Zhang J CNS Neurosci Ther; 2024 Feb; 30(2):e14393. PubMed ID: 37563872 [TBL] [Abstract][Full Text] [Related]
10. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies. Peng C; Gathagan RJ; Lee VM Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258 [TBL] [Abstract][Full Text] [Related]
11. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis. Mehra S; Sahay S; Maji SK Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581 [TBL] [Abstract][Full Text] [Related]
12. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy. Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276 [TBL] [Abstract][Full Text] [Related]
13. Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy. Chatterjee D; Sanchez DS; Quansah E; Rey NL; George S; Becker K; Madaj Z; Steiner JA; Ma J; Escobar Galvis ML; Kordower JH; Brundin P J Parkinsons Dis; 2019; 9(2):315-326. PubMed ID: 30932894 [TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Soper JH; Roy S; Stieber A; Lee E; Wilson RB; Trojanowski JQ; Burd CG; Lee VM Mol Biol Cell; 2008 Mar; 19(3):1093-103. PubMed ID: 18172022 [TBL] [Abstract][Full Text] [Related]
15. The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease. Benskey MJ; Perez RG; Manfredsson FP J Neurochem; 2016 May; 137(3):331-59. PubMed ID: 26852372 [TBL] [Abstract][Full Text] [Related]
16. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies? Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118 [TBL] [Abstract][Full Text] [Related]
17. Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies. Fayyad M; Majbour NK; Vaikath NN; Erskine D; El-Tarawneh H; Sudhakaran IP; Abdesselem H; El-Agnaf OMA Neurosci Lett; 2020 Apr; 725():134899. PubMed ID: 32156613 [TBL] [Abstract][Full Text] [Related]
18. Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson's Disease Treatment. Kalsoom I; Wang Y; Li B; Wen H Mini Rev Med Chem; 2023; 23(20):1959-1974. PubMed ID: 37198991 [TBL] [Abstract][Full Text] [Related]
19. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports. Lashuel HA Neurobiol Dis; 2020 Jul; 141():104876. PubMed ID: 32339655 [TBL] [Abstract][Full Text] [Related]
20. Deficiency of the serine peptidase Kallikrein 6 does not affect the levels and the pathological accumulation of a-synuclein in mouse brain. Samantha Sykioti V; Karampetsou M; Chalatsa I; Polissidis A; Michael IP; Pagaki-Skaliora M; Nagy A; Emmanouilidou E; Sotiropoulou G; Vekrelli S K J Neurochem; 2021 Jun; 157(6):2024-2038. PubMed ID: 32974895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]